Article
XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls.
Medicine - 10 Jul 2020
Qin Feng, Gao Sheng-Lin, Xu Kai, Su Quan-Xin, Zhang Ze, Shi Li, Zhu Li-Jie, Zhang Li-Feng, Zuo Li
Abstract excerpt
BACKGROUND: Previous studies have investigated the correlation between xeroderma pigmentosumcomplementation group C (XPC) variants and prostate adenocarcinoma (PA) risk. Nevertheless, research findings remain inconclusive. METHODS: We conducted a pooled analysis to obtain a more accurate estimation of the relationship on XPC exon15 Lys939Gln polymorphism with susceptibility to PA. Moreover, in silico tools were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
